Stem Cells Are Regenerating Medical Field by Dr. David Greene Arizona

Dr. David Greene, the Founder, and CEO of R3 Stem Cell has been featured on the cover of Corporate Vision magazine for July 2021. Dr. Greene’s company is the leader in global regenerative therapies, with over 16,000 stem cell procedures performed worldwide in the past decade.

Stem cell therapy is one of the new terms introduced in the field of medical science. It has received a lot of coverage around the world.

R3’s Major Assets Since the start, Dr. David Greene Arizona and his team put their focus on major aspects of R3. Now, these major aspects of R3 become Assets of the company.

According to Dr. Greene, these assets are the reason for their success.

Breadth: With the growth of R3, the team of R3 also believes in growing people who join with them. To do this, R3 also increases the types of services they offer. The R3 provides services like patient education, provider education, top-quality biologic with training, and extensive marketing.

Responsiveness: Listening to the patient’s and client’s feedback about shortcomings are what R3 believes in. Working on the flaws allowed R3 to improve and increase the value addition for their clients. And by doing so, it becomes the biggest reason for success.

Quality: Dr. David Greene believes that “the actual magic occurs in the lab.“ While performing regenerative therapies, “the quality of biology is essential,” so R3 always ensures the presence of top-quality biologic at every R3 center.

Safety: With no doubt, safety comes first in every aspect. In the past years, 16,000 regenerative procedures were performed

by R3 stem cells. And keeping safety as a top priority, all their procedure is done without any adverse occurrences.

Accountability: Accountability is one of R3’s defining values. And they believe in honesty. No doubt the R3 team works efficiently and incredibly hard. But there are sometimes when things don’t go as planned. But, with an open channel of communication, they work side by side to resolve the problem.

At last, Dr. Greene’s R3 considers patient satisfaction as a top priority. When a patient shares that their investment in stem cell therapy improves their quality of life more than the cost involved. This is what satisfies Dr. Greene and his team, and reminds him “why he started R3!”